Ranking · Summer 2022 · Healthcare · Healthcare IT

KemNet

KemNet supplies reformulated drugs for specific groups of patients.

4.1%

odds of being acquired in the next two years

0.6× the average (6.8%)

#4008 of 4,339 active YC companies · top 93%

Team of 2 · Victoria, BC, Canada; Edmonton, AB, Canada; Remote

Raises the odds

↑ based in Fully Remote

↑ based in America / Canada

↑ based in Remote

Lowers the odds

↓ team of 1–2

↓ industry: Healthcare

↓ tag: Marketplace

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads KemNet's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

kemnet.ca YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub